Publications by authors named "Kevin Hicks"

Claim this Profile
P
Progesterone receptor membrane component 1 (PGRMC1) regulates Heme trafficking through mitochondria-ER junctions.
Robert B Piel Iii, Chibuike D Obi, Martonio Ponte Viana, Mathilda M Willoughby, Osiris Martinez-Guzman, Kevin G Hicks

J Inorg Biochem· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic metabolite screening identifies functional regulators of the adenosine A2A receptor.
Prashant Rao, Manoj Rathinaswamy, Michelle Chan, Andrea Guzmán Paredes, Chirag Patel, Kevin G Hicks

Commun Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging implementation science to enhance the adoption of DPYD testing.
Sony Tuteja, J Kevin Hicks, Larisa H Cavallari, Nihal El Rouby, D Max Smith

Pharmacogenet Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of FicD-mediated AMPylation and deAMPylation by Isoprenoid Diphosphates.
Aubrie M Blevins, Wei Peng, Lisa N Kinch, Zihan Monshad, Andrea G Paredes, Kevin G Hicks

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with frontline immune checkpoint inhibitors among individuals with -mutant non-small cell lung cancer.
Julian A Marin-Acevedo, Ram Thapa, Sudeepthi V Bandikatla, Dung-Tsa Chen, J Kevin Hicks

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention times.
Christelle Colin-Leitzinger, Yonatan Ayalew Mekonnen, Isis Narvaez-Bandera, Vanessa Y Rubio, Dalia Ercan, Kevin Hicks

Metabolomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An examination of factors associated with disparities in clinical trial eligibility guided by the Socioecological Model.
Yayi Zhao, Rossybelle P Amorrortu, J Kevin Hicks, Melany A Garcia, Eric B Haura

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Variants in a Pan-Cancer Cohort.
Pamela L Brock, Morgan Webster, Sandya Liyanarachchi, Lindsey Byrne, Dale J Hedges, J Kevin Hicks

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.
Teresa T Ho, D Max Smith, Christina L Aquilante, Emily J Cicali, Nihal El Rouby, J Kevin Hicks

Clin Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.
Larisa H Cavallari, J Kevin Hicks, Jai N Patel, Amanda L Elchynski, D Max Smith

Pharmacogenet Genomics· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nelson et al. Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. 2021, , 1566.
Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto, J Kevin Hicks

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical Care.
Aileen Y Alontaga, Pedro Cano, Hilal Ozakinci, John A Puskas, Paul A Stewart, J Kevin Hicks

J Mol Diagn· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US.
Tabea Tracksdorf, D Max Smith, Skyler Pearse, Emily J Cicali, Christina L Aquilante, J Kevin Hicks

Support Care Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding Pharmacogenomic Test Interpretation and Application to Patient Care.
Roseann S Donnelly, Larisa H Cavallari, Jeannine S McCune, Jennifer Trofe-Clark, Christine M Formea, J Kevin Hicks

J Am Coll Clin Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Founder Variants and Thyroid Cancer Risk.
Pamela Brock, Sandya Liynarachchi, Taina T Nieminen, Carlos Chan, Wendy Kohlmann, J Kevin Hicks

Thyroid· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Tikvah K Hayes, Elisa Aquilanti, Nicole S Persky, Xiaoping Yang, Erica E Kim, J Kevin Hicks

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Tikvah K Hayes, Elisa Aquilanti, Nicole S Persky, Xiaoping Yang, Erica E Kim, J Kevin Hicks

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.
Scott A Mosley, Emily Cicali, Alex Del Cueto, Diane G Portman, Kristine A Donovan, J Kevin Hicks

Pharmacotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy.
Daniel L Hertz, D Max Smith, Stuart A Scott, Jai N Patel, J Kevin Hicks

Clin Pharmacol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports.
Todd C Knepper, Theresa A Boyle, J Kevin Hicks, Christine M Walko

JCO Oncol Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.
Nathan D Seligson, Jill M Kolesar, Benish Alam, Laura Baker, Jatinder K Lamba, J Kevin Hicks

Pharmacogenomics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks

Clin Pharmacol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, Alissa J Cooper, Neal S Akhave, J Kevin Hicks

Cancer Discov· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer.
Avani M Singh, Rafael Rubiera-Pebe, Yaser Ahmad, Michael Shafique, J Kevin Hicks

JCO Oncol Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.
Lydia P Liew, Avik Shome, Way W Wong, Cho R Hong, Kevin O Hicks

Molecules· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis